糖尿病患者并发社区获得性肺炎的相关因素及治疗措施-国际临床研究杂志-CSCIED科技核心评价数据库-手机版

糖尿病患者并发社区获得性肺炎的相关因素及治疗措施

Related factors and treatment of community acquired pneumonia in diabetic patients

ES评分 0 浏览量：719 下载量：1

DOI	10.12208/j.ijcr.20220379
刊名	国际临床研究杂志 International Journal of Clinical Research
年，卷(期)	2022, 6(8)
作者	廖理菊*,
作者单位	北京市海淀区甘家口社区卫生服务中心北京 ;
摘要	分析糖尿病患者并发社区获得性肺炎的相关因素和治疗方法。方法选择我院2019年-2020年糖尿病患者并发社区获得性肺炎30例为研究对象，选择2019年-2020年单纯性糖尿病患者30例为参照对象，分析年糖尿病患者并发社区获得性肺炎相关因素，并根据相关因素，制定相应的治疗措施。结果糖尿病患者并发社区获得性肺炎的相关因素有高龄、肺部基础性疾病以及HbAC1，（P<0.05）为差异显著，有统计学意义。患者治疗后TNF-a水平,IL-8水平,NF-KB水平、IL-6水平、CRP水平明显降低，（P<0.05）为差异显著，有统计学意义。结论积极控制血糖，稳定基础疾病，能够降低社区获得性肺炎发生率。阿奇霉素联合头孢他啶治疗糖尿病患者并发社区获得性肺炎效果较明显，值得临床重视并采纳。
Abstract	Objective: To analyze the related factors and treatment of community-acquired pneumonia in patients with diabetes. Methods: 30 patients with diabetes complicated with community-acquired pneumonia in our hospital from 2019 to 2020 were selected as the research object, and 30 patients with simple diabetes from 2019 to 2020 were selected as the reference object. The relevant factors of diabetes patients complicated with community-acquired pneumonia in were analyzed, and the corresponding treatment measures were formulated according to the relevant factors. Results: The related factors of diabetes patients complicated with community-acquired pneumonia were old age, basic pulmonary diseases and HbAc1 (P < 0.05), which were statistically significant. After treatment, the levels of TNF-a, IL-8, NF-kB, IL-6 and CRP in the patients were significantly decreased (P < 0.05), which was statistically significant. Conclusion: actively controlling blood glucose and stabilizing basic diseases can reduce the incidence of community-acquired pneumonia. Azithromycin combined with ceftazidime is effective in the treatment of diabetes patients complicated with community-acquired pneumonia, which is worthy of clinical attention and adoption.
关键词	糖尿病；社区获得性肺炎；相关因素；治疗措施；分析
KeyWord	Diabetes; Community Acquired Pneumonia; Relevant Factors; Treatment Measures; Analysis
基金项目
页码	119-121

参考文献
相关文献

[1] 赵欣,沈英,黄超.头孢他啶联合左氧氟沙星治疗社区获得性肺炎的临床效果[J].临床合理用药杂志,2022,15(19): 63-65.

[2] 余小丽,俞婷,陈愉生等.80岁以上老年人社区获得性肺炎的临床特点及病原学分析[J].中国呼吸与危重监护杂志,2022,21(02):90-95.

[3] 蔡爱民,张祖良,周琪等.糖尿病合并社区获得性肺炎患者痰标本中病原菌分布及抗菌药物使用情况分析[J].抗感染药学,2021,18(10):1523-1525.

[4] 张珏,刘芹芹,何文辉等.不同降糖策略对老年糖尿病合并社区获得性肺炎非重症患者疗效的影响[J].中国初级卫生保健,2021,35(08):88-91.

[5] 陈亮,韩秀迪,李艳丽等.糖尿病合并社区获得性肺炎住院患者临床特征和死亡危险因素分析[J].中国糖尿病杂志,2021,29(01):14-19.

[6] 杨燕丽,张秋玲,杨璐等.老年2型糖尿病患者隐匿性肺部感染病原学及其危险因素[J].中华医院感染学杂志,2021,31(01):1-5.

[7] 朱伟,胡量子.老年糖尿病伴重症肺炎患者血清炎性反应及降钙素原变化的临床意义[J].吉林医学,2020,41(08): 1840-1841.

[8] 夏阳.老年糖尿病合并社区获得性肺炎的分析[J].中国社区医师,2020,36(14):62-63.

[9] 王友香.血清脑钠肽、胰岛素抵抗指数水平与老年2型糖尿病合并重症肺炎患者病情严重程度及预后关系[J].糖尿病新世界,2022,25(10):28-31.

引用本文

廖理菊*. 糖尿病患者并发社区获得性肺炎的相关因素及治疗措施 [J]. 国际临床研究杂志. 2022; 6; (8). 119 - 121.

文献评论

相关学者

相关机构